When we last reported on RNs pushing propofol, patient safety was at the heart of the story. And it still is, because the drug's label and several state nursing boards still say that no one other than trained anesthesia providers should be pushing this drug. But the debate intensified when the American College of Gastroenterology petitioned the FDA in June to strike from the warning label of the sedative-hypnotic two key provisions:

• only those persons trained in the administration of general anesthesia should administer the drug and
• only those persons not involved in the conduct of surgical/diagnostic procedure should administer the drug.